A diagnostic smell test for early detection of neurodegenerative diseases
This diagnostic device measures smell adaptation to detect early-stage neurodegenerative diseases such as Parkinson’s Disease and Alzheimer’s Disease. Existing detection methods for neurological diseases include expensive brain imaging tests and invasive blood tests. This method measures early-stage disease by measuring a patient’s adaptation to new smells.
An antibody designed to regulate anxiety and digestion
This antibody cross-reacts with mouse protein CCK2 and its human homolog, which helps to regulate anxiety, digestion and locomotion. This antibody is expected to be useful for studies in the central nervous system, gastrointestinal tract and other organs.
An antibody designed to defend against eye disease in horseshoe crabs
These antibodies are raised against the N-terminal half of recombinant visual arrestin in horseshoe crabs. This protein interrupts light-activated signal transduction in the eye, causing an autoimmune eye disorder, and is specific to horseshoe crabs, species-wide.
An antibody designed to slow visual recovery
These biological materials are designed to block the protein recoverin, a neurologically important calcium binding protein. Recoverin aids in the adaptation to background light and in the recovery phase of visual excitation.